Latest KFF Health News Content

Latest KFF Health News Stories

Anthem Reports Higher-Than-Expected Enrollment Numbers

Morning Briefing

Anthem’s strong 2016 forecast has given a boost to its peer group, with the four largest insurers seeing a bump in market value. In other news from the industry, the CEO of Aetna predicts the Humana deal will close this year and says he will not withdraw from the public health exchange market.

Executives: Outrage Over Pharma Profiteering Is ‘Perversion Of Reality’

Morning Briefing

The drug makers defended their products as life saving, and dismissed concerns over prices as “more of a campaign issue than an actual issue.” In other pharmaceutical news, a California cost transparency bill is shelved and the Pfizer and Allergan CEOs tout plans to boost medicine production.

Bernie Sanders Defends Health Care Record Against Hillary Clinton Jabs

Morning Briefing

Meanwhile, Chelsea Clinton kept up the drumbeat, warning younger voters that her mother’s opponent wants to “dismantle Obamacare,” the CHIP program, Medicare and private insurance. The Sanders campaign called the Clinton attacks “wrong.”

New Louisiana Governor Signs Order For Medicaid Expansion

Morning Briefing

The action by Democrat John Bel Edwards fulfills a campaign promise. Also in two state-of-the-state speeches, governors in South Dakota and Kansas take different views of the health law’s provision to expand health coverage for low-income residents.

Obama Takes Health Law Push Outside Beltway

Morning Briefing

The president plans to spend much of the year outside of Washington, D.C., with two of his first stops in Nebraska and Louisiana, where he will press for Medicaid expansion. U.S. News & World Report looks at how the Affordable Care Act’s success lives and dies in the states.

Senate HELP Committee Approves FDA Nominee

Morning Briefing

Robert Califf, the president’s pick to lead the Food and Drug Administration, is expected to get full Senate confirmation easily. However, Vermont Sen. Bernie Sanders, a candidate for the Democratic presidential nomination, voted against him, citing concerns with Califf’s pharmaceutical ties.

President Puts Biden In Charge Of ‘Mission Control’ For Cancer Moonshot

Morning Briefing

In his final State of the Union address, Obama announced the vice president would be leading a charge against the disease, saying, “Let’s make America the country that cures cancer once and for all.” But, experts say, curing cancer doesn’t look like a single moonshot — it’s an ever changing battlefield with hundreds or thousands of different enemies to swarm.

Obama Returns To Message Of Hope In Final State Of The Union

Morning Briefing

With only passing mentions of policy initiatives, President Barack Obama used his last State of the Union more to address the nation than Congress. He painted a bright picture of the country’s standing and called on Americans to replace him with someone who would continue to carry out his reforms on health care, climate change and Iran, among others.

Nestle Invests In ‘Healthy Gut’ Products

Morning Briefing

Meanwhile, research links heartburn drugs to kidney disease risk. And news outlets report on other public health developments including a hospital program aimed at reducing falls by older adults, youth sports concussion policies and a nurse who reunites with a woman who cared for her as a toddler.

Shire-Baxalta $32B Merger Would Create Powerhouse Rare-Disease Drugmaker

Morning Briefing

Big companies used to steer clear of rare-disease drugs because there aren’t enough patients to make them profitable, but that has changed as the market has sustained high prices. In other pharmaceutical news, drug companies launch a cooperative effort to fight cancer, the Supreme Court lets a ruling on deceptive marketing of an anti-psychotic drug stand, and states look at ways to combat high prices.

Task Force Maintains That Fewer Mammograms Are Needed

Morning Briefing

The final set of guidelines from the government panel supports a range of choices for women when it comes to breast cancer screening. They recommend women in their 50s get a mammogram every two years, but women in their 40s should weigh the pros of early detection against the cons of a false positive, which could bring anxiety and unnecessary medical treatment with it. The guidelines are already proving controversial as advocates and lawmakers back early screenings.

CMS To Expand Care With 21 ‘Next Generation ACOs’

Morning Briefing

The accountable care organizations work to improve quality and lower costs, with measures as simple as making sure patients receive regular follow-up visits and stay on their medications.